Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas.

Journal of neuroradiology = Journal de neuroradiologie - 1 Jan 2022

Shin Ilah, Park Yae Won, Ahn Sung Soo, Kang Seok-Gu, Chang Jong Hee, Kim Se Hoon, Lee Seung-Koo

Abstract excerpt

BACKGROUND AND PURPOSE: Increasing evidence suggests that genomic and molecular markers need to be integrated in grading of meningioma. Telomerase reverse transcriptase promoter (TERTp) mutation is receiving attention due to its clinical relevance in the treatment of meningiomas. The predictive ability of conventional and diffusion MRI parameters for determining the TERTp mutation status in grade II meningiomas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diffusion Magnetic Resonance Imaging

Share to Meningeal Neoplasms

Share to Meningioma

Share to Mutation

Share to Telomerase

Source

Identifiers

PMID: 33716047
DOI: 10.1016/j.neurad.2021.02.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas.PMID 33716047Read ↗

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.Semantic proximity Read ↗

Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas.Semantic proximity Read ↗

Feasibility of Evaluating the Histologic and Genetic Subtypes of WHO Grade II-IV Gliomas by Diffusion-Weighted ImagingSemantic proximity Read ↗

TERT Promoter Mutations and Risk of Recurrence in Meningioma.Semantic proximity Read ↗

TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.Semantic proximity Read ↗

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.Semantic proximity Read ↗

Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.Semantic proximity Read ↗

Meningiomas: A review of general, histopathological, clinical and molecular characteristics.Semantic proximity Read ↗

Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas.Semantic proximity Read ↗

Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.Semantic proximity Read ↗

Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.Semantic proximity Read ↗

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.